EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction

Maurizio Bertaina iD, Nuccia Morici, Simone Frea, Laura Garatti, Martina Briani, Carlotta Sorini, Luca Villanova, Elena Corrada, Alice Sacco, Marco Moltrasio, Amelia Ravera, Michele Tedeschi und 19 weitere

ESC Heart Failure · 2023

DOI: 10.1002/ehf2.14510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2023. Verfasst von Maurizio Bertaina und 30 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy. Hauptthemen laut MEDLINE: Myocardial Infarction, Heart Failure, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The present analysis from the multicentre prospective Altshock-2 registry aims to better define clinical features, in-hospital course, and management of cardiogenic shock complicating acutely decompensated heart failure (ADHF-CS) as compared with that complicating acute myocardial infarction (AMI-CS). Methods and results All patients with AMI-CS or ADHF-CS enrolled in the Altshock-2 registry between March 2020 and February 2022 were selected. The primary objective was the characterization of ADHF-CS patients as compared with AMI-CS. In-hospital length of stay and mortality were secondary endpoints. One-hundred-ninety of the 238 CS patients enrolled in the aforementioned period were considered for the present analysis: 101 AMI-CS (80% ST-elevated myocardial infarction and 20% non-ST-elevated myocardial infarction) and 89 ADHF-CS. As compared with AMI-CS, ADHF-CS patients were younger [63 (IQR 59–76) vs. 67 (IQR 54–73) years, P = 0.01], but presented with higher creatinine [1.6 (IQR 1.0–2.6) vs. 1.2 (IQR 1.0–1.4) mg/dL, P < 0.001], bilirubin [1.3 (IQR 0.9–2.3) vs. 0.6 (IQR 0.4–1.1) mg/dL, P = 0.01], and central venous pressure values [14 mmHg (IQR 8–12) vs. 10 mmHg (IQR 7–14),P = 0.01]. Norepinephrine was the most common catecholamine used in AMI-CS (79.3%), whereas epinephrine was used more commonly in ADHF-CS (65.5%); 75.8% vs. 46.6% received a temporary mechanical support in AMI-CS and ADHF-CS, respectively (P < 0.001). Length of hospital stay was longer in the latter [28 (IQR 13–48) vs. 17 (IQR 9–29) days, P = 0.001]. Heart replacement therapies were more frequently used in the ADHF-CS group (heart transplantation 13.5% vs. 0% and left ventricular assist device 11% vs. 2%, P < 0.01 and 0.01, respectively). In-hospital mortality was 41.1% (38.6% AMI-CS vs. 43.8% ADHF-CS, P = 0.5).

Conclusions

ADHF-CS is characterized by a higher prevalence of end-organ and biventricular dysfunction at presentation, a longer hospital length of stay, and higher need of heart replacement therapies when compared with AMI-CS. In-hospital mortality was similar between the two aetiologies. Our data warrant development of new management protocols focused on CS aetiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionHeart FailureST Elevation Myocardial InfarctionHumansShock, CardiogenicProspective Studies

Stichwörter der Autor:innen

Cardiogenic shockHeart failureMortalityMyocardial infarction

Autor:innen und Institutionen

  • Division of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy.
  • IRCCS S. Maria Nascente-Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
  • Intensive Cardiac Care Unit, Città della Salute e della Scienza di Torino, Turin, Italy.
  • Cardiology Department and De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Humanitas Research Hospital, IRCCS Rozzano, Milan, Italy.
  • Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

ORCID-Profile: Maurizio Bertaina

Zitieren

APA

Bertaina, M., Morici, N., Frea, S., Garatti, L., Briani, M., Sorini, C., Villanova, L., Corrada, E., Sacco, A., Moltrasio, M., Ravera, A., Tedeschi, M., Bertoldi, L., Lettino, M., Saia, F., Corsini, A., Camporotondo, R., Colombo, C. N. J., Bertolin, S., …, & Tavazzi, G. (2023). Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction. ESC Heart Failure. https://doi.org/10.1002/ehf2.14510

Vancouver

Bertaina M, Morici N, Frea S, Garatti L, Briani M, Sorini C, et al. Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction. ESC Heart Failure. 2023. doi:10.1002/ehf2.14510

BibTeX
@article{Bertaina2023,
  author = {Bertaina, Maurizio and Morici, Nuccia and Frea, Simone and Garatti, Laura and Briani, Martina and Sorini, Carlotta and Villanova, Luca and Corrada, Elena and Sacco, Alice and Moltrasio, Marco and Ravera, Amelia and Tedeschi, Michele and Bertoldi, Letizia and Lettino, Maddalena and Saia, Francesco and Corsini, Anna and Camporotondo, Rita and Colombo, Costanza Natalia Julia and Bertolin, Stephanie and Rota, Matteo and Oliva, Fabrizio and Iannaccone, Mario and Valente, Serafina and Pagnesi, Matteo and Metra, Marco and Sionis, Alessandro and Marini, Marco and De Ferrari, Gaetano Maria and Kapur, Navin K and Pappalardo, Federico and Tavazzi, Guido},
  title = {Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction},
  journal = {ESC Heart Failure},
  year = {2023},
  doi = {10.1002/ehf2.14510}
}
Kostenlos starten →